76 related articles for article (PubMed ID: 19373613)
1. Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.
Clubbs EA; Bomser JA
Nutr Cancer; 2009; 61(3):390-6. PubMed ID: 19373613
[TBL] [Abstract][Full Text] [Related]
2. Glycitein activates extracellular signal-regulated kinase via vascular endothelial growth factor receptor signaling in nontumorigenic (RWPE-1) prostate epithelial cells.
Clubbs EA; Bomser JA
J Nutr Biochem; 2007 Aug; 18(8):525-32. PubMed ID: 17156992
[TBL] [Abstract][Full Text] [Related]
3. Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways.
Wang X; Clubbs EA; Bomser JA
J Nutr Biochem; 2006 Mar; 17(3):204-10. PubMed ID: 16198100
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.
Kim MH; Gutierrez AM; Goldfarb RH
Anticancer Res; 2002; 22(6C):3811-7. PubMed ID: 12552999
[TBL] [Abstract][Full Text] [Related]
5. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; van Bokhoven A; Johannes WU; Nordeen SK; Ogden LG
Prostate; 2006 Apr; 66(5):557-66. PubMed ID: 16372328
[TBL] [Abstract][Full Text] [Related]
6. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of genistein on the proliferation of RWPE-1 cells induced by testosterone under the control of insulin-like growth factor-1].
Ren G; Tang L; Zhu M; Yang L; Huang Y
Wei Sheng Yan Jiu; 2010 Jul; 39(4):447-50. PubMed ID: 20726235
[TBL] [Abstract][Full Text] [Related]
8. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
Tokar EJ; Ancrile BB; Cunha GR; Webber MM
Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
11. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
12. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
[TBL] [Abstract][Full Text] [Related]
13. Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line.
Albrecht AL; Somji S; Sens MA; Sens DA; Garrett SH
Biometals; 2008 Aug; 21(4):405-16. PubMed ID: 18097638
[TBL] [Abstract][Full Text] [Related]
14. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
15. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo.
Yamasaki M; Fujita S; Ishiyama E; Mukai A; Madhyastha H; Sakakibara Y; Suiko M; Hatakeyama K; Nemoto T; Morishita K; Kataoka H; Tsubouchi H; Nishiyama K
Cancer Sci; 2007 Nov; 98(11):1740-6. PubMed ID: 17727682
[TBL] [Abstract][Full Text] [Related]
16. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
Katdare M; Osborne M; Telang NT
Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
[TBL] [Abstract][Full Text] [Related]
17. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.
Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U
Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108
[TBL] [Abstract][Full Text] [Related]
18. The specific role of isoflavones in reducing prostate cancer risk.
Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
[TBL] [Abstract][Full Text] [Related]
19. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line.
Albrecht AL; Singh RK; Somji S; Sens MA; Sens DA; Garrett SH
J Appl Toxicol; 2008 Apr; 28(3):283-93. PubMed ID: 17590860
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of O-methylated isoflavone glycitein on human breast cancer SKBR-3 cells.
Zhang B; Su JP; Bai Y; Li J; Liu YH
Int J Clin Exp Pathol; 2015; 8(7):7809-17. PubMed ID: 26339345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
